CSPC Pharmaceutical Initiates Phase III Trial Of HB1801 For Advanced Breast Cancer In China
Sept 24 (Reuters) - CSPC PHARMACEUTICAL GROUP LIMITED 1093.HK:
PHARMA INITIATES PHASE III TRIAL OF HB1801 FOR ADVANCED BREAST CANCER IN CHINA
Further company coverage: 1093.HK